Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
16 April 2020 | Story Department of Communication and Marketing | Photo Charl Devenish
Farmovs
In 2019, FARMOVS was pre-qualified by the WHO to support clinical studies aimed at improving access to quality generic medicines across the globe.

The University of the Free State (UFS) is committed to supporting government’s efforts to overcome the COVID-19 pandemic. During this challenging time, dedicated staff members at the UFS continue to provide services as a testimony to their commitment to advance public knowledge of COVID-19 for the greater good of South Africa.

The following is a synopsis of the areas in which the UFS is actively assisting.

Public Health Emergency Solidarity Trial
Clinicians from the Department of Internal Medicine, the Department of Critical Care, and the Division of Virology will be working with FARMOVS to participate in the Public Health Emergency Solidarity Trial initiated by the World Health Organization (WHO). This international randomised trial will evaluate four treatment options (remdesivir, lopinavir/ritonavir, lopinavir/ritonavir plus interferon, chloroquine or hydroxychloroquine) for the treatment of COVID-19. 

The trial is expected to include more than 45 countries worldwide, including a number of South African sites. 

Farmovs

FARMOVS is in a planning process to support all the Bloemfontein hospitals, including Pelonomi, Universitas, 3 Military Hospital, Mediclinic, and Rosepark, in conducting the largest global trial on COVID-19 – the Public Health Emergency Solidarity Trial, under leadership of the WHO.   

Negotiations are ongoing between the UFS and the Department of Health in the Free State for FARMOVS to offer support with the continuation of healthcare to non-COVID-19 patients in an attempt to free up space at Universitas Hospital for isolation of COVID-19 patients. 

In 2019, FARMOVS was pre-qualified by the WHO to support clinical studies aimed at improving access to quality generic medicines across the globe.  FARMOVS also receives feasibility requests for support with the evaluation of existing drugs (repurposing) as well as the development of novel drugs for the treatment of COVID-19 – this is an ongoing process.

Disaster Management Training and Education Centre (DiMTEC)
DiMTEC represents the UFS on the Provincial Joint Operation Centre (PROVJOC). The PROVJOC is a fully equipped, dedicated facility that is proactively established to enable all relevant role players /disciplines to jointly manage all safety and security-related aspects of any planned event or any major incident which has occurred or is imminent – especially in the response and recovery operations phase – at the strategic and/or tactical level, using the Unified Command System. This facility is also linked to all other established safety and security centres.

Research and Innovation
The UFS hosts a SARChI Research Chair in vector-borne and zoonotic diseases, and recently invested in the establishment of a biosafety level-3 facility. Hence, there is expertise on the campus to plan and conduct research on zoonotic and medically significant viruses. In addition, there are research groups focusing on protein expression systems with potential for utilisation in the development of diagnostic assays with application in either diagnosis or surveillance.

Currently, researchers at the UFS have established several projects that will contribute directly towards the COVID-19 outbreak.


News Archive

Department celebrates 50th anniversary
2009-03-25

 
The first Departmental Head and the subsequent Departmental Chairpersons at the dinner on 14 March this year. From left: Proff Bernard Prior (1991-1998), Piet Lategan (1962-1990), Derek Litthauer (1998-2002) and James du Preez (2002-). These are all the Heads/Chairpersons of the Department since its founding in 1959, with the exception of Prof Hans Potgieter who acted as Head during 1959-1962.
Photo: Stephen Collett
 
Department celebrates 50th anniversary

On 13 March the Department Microbial, Biochemical and Food Biotechnology at the University of the Free State (UFS) celebrated its 50th anniversary in a splendid fashion with a lecture entitled, The origin of life: Exactly how did life begin? as part of the Darwin commemorative lecture series, followed by a reunion of current and former staff members and postgraduate students of the department with a barbeque on the following day.

The proceedings were concluded on 14 March with a gala dinner in die Centenary Complex at the UFS attended by 153 staff members, post-graduate students (current and former) and other guests. During the dinner the guests were treated to a presentation of historical photos of the founding and development of the department. Currently the department is one of the largest departments in the Faculty of Natural and Agricultural Sciences in respect of the number of staff members and students as well as research outputs. This is the result of entrepreneurial actions to increase student numbers and research activities, as well as the merging with the smaller Department of Biochemistry in 1988 and more recently with the Department of Food Science in 2002. The department comprises 20 academics, 24 support staff and 65 postgraduate students. It also boasts 12 lecturers with ratings from the National Research Foundation (NRF), which include three academics with a B-rating, an indication of international recognition for their research. The department has the largest number of lecturers with an NRF-rating at the UFS. 

“It was interesting to learn during the reunion of the variety of professions occupied by former students of the department, i.e. at other tertiary educational institutions, the CSSIR, SAPPI, Sasol and a multitude of other industries, as well as at research institutions in the USA and Australia,” said Prof. James du Preez, Head of the Department.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept